Successful treatment with tolvaptan to control blood volume and hyponatremia in a chronic kidney disease patient

CEN Case Reports
Tomoyuki YamazakiEiji Kusano

Abstract

We report a case of successful treatment with tolvaptan (15 mg/day) in a 73-year-old female patient with chronic kidney disease (CKD) stage 5 due to diabetic nephropathy and renal sclerosis for volume control and loop diuretic-induced hyponatremia. Her creatinine clearance has remained at 7-10 ml/min for the last 6 months. She was treated by dietary and drug therapy, namely, antihypertensives (nifedipine: 40 mg/day, olmesartan: 20 mg/day) and loop diuretics (azosemide: 40-120 mg/day), for CKD and concomitant diseases of hypertension and diabetic mellitus. She developed loop diuretic-induced hyponatremia (120 mmol/l) by increased sodium excretion, but the diuretic was required for the control of volume overload. Hence, azosemide was suspended and tolvaptan (15 mg/day) was administered. After tolvaptan treatment, the plasma sodium level gradually increased to a normal level (135-140 mmol/l) and volume overload was improved. Urine volume was maintained at about 1000 ml/day with low sodium excretion (<40 mmol/day) and increased free water clearance. These results suggest that tolvaptan may be effective for volume control and diuretic-induced hyponatremia in CKD patients.

References

Dec 1, 1996·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·V M BuckalewG Schulman
Jan 16, 2002·Journal of Hypertension·Robert A AugustyniakRonald G Victor
Sep 15, 2004·Journal of the American College of Cardiology·John M McCurleyMark C Haigney
Apr 12, 2006·Archives of Internal Medicine·Alexander GoldbergDoron Aronson
Nov 16, 2006·The New England Journal of Medicine·Robert W SchrierUNKNOWN SALT Investigators
Mar 27, 2007·JAMA : the Journal of the American Medical Association·Marvin A KonstamUNKNOWN Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST) Investigators
Aug 25, 2009·The American Journal of Medicine·Sushrut S WaikarGary C Curhan
Feb 27, 2010·Journal of the American Society of Nephrology : JASN·Tomas BerlUNKNOWN SALTWATER Investigators
Sep 10, 2011·Clinical Journal of the American Society of Nephrology : CJASN·Eiji HigashiharaUNKNOWN TEMPOFormula and 156-05-002 Study Investigators

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.